Marek Szwiec

Zielona Gora, LB, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.

Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.

Journal: Hereditary cancer in clinical practice

Published: May 13, 2026

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study.

Real-world outcomes with palbociclib, ribociclib, and abemaciclib plus endocrine therapy in HR+/HER2- advanced breast cancer: A multicenter retrospective study.

Journal: Breast (Edinburgh, Scotland)

Published: October 12, 2025

Germline ATRIP variants and the risk of ovarian cancer.

Germline ATRIP variants and the risk of ovarian cancer.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: July 03, 2025

Real-world efficacy and safety of nivolumab and ipilimumab in metastatic renal cell carcinoma: a Polish multicenter study.

Real-world efficacy and safety of nivolumab and ipilimumab in metastatic renal cell carcinoma: a Polish multicenter study.

Journal: Future oncology (London, England)

Published: May 20, 2025

Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women.

Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish Women.

Journal: International journal of molecular sciences

Published: May 08, 2025

Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland.

Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland.

Journal: Frontiers in oncology

Published: April 24, 2025

BRCA1 promoter hypermethylation is not associated with germline variants in Polish breast cancer patients.

BRCA1 promoter hypermethylation is not associated with germline variants in Polish breast cancer patients.

Journal: Hereditary cancer in clinical practice

Published: April 17, 2025

Sociodemographic and clinical factors related to high rates of unmet supportive care needs among Polish cancer patients.

Sociodemographic and clinical factors related to high rates of unmet supportive care needs among Polish cancer patients.

Journal: Frontiers in psychology

Published: March 03, 2025

Cancer related information that cancer patients need.

Cancer related information that cancer patients need.

Journal: Scientific reports

Published: February 13, 2025

The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy.

The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy.

Journal: Cancers

Published: January 27, 2025

Prognostic significance of peripheral blood biomarkers in patients with advanced renal cell carcinoma treated with nivolumab and ipilimumab-a polish multicenter, observational study.

Prognostic significance of peripheral blood biomarkers in patients with advanced renal cell carcinoma treated with nivolumab and ipilimumab-a polish multicenter, observational study.

Journal: Clinical and experimental medicine

Published: October 22, 2024

Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.

Blood molybdenum level as a marker of cancer risk on BRCA1 carriers.

Journal: Hereditary cancer in clinical practice

Published: August 01, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026